FDA Inspection 1097900 — New York Blood Center Inc
The FDA completed an inspection of New York Blood Center Inc on June 20, 2019 in St. Paul, MN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 20, 2019
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- St. Paul, MN (United States)